(3R,4R)-Methyl 4-(4-chlorophenyl)-1-methylpiperidine-3-carboxylate

Catalog No. :
ACYQSG142
CAS No. :
205805-13-6
Molecular Formula :
C14H18ClNO2
Molecular Weight :
267.76

IUPAC Name:methyl (3R,4R)-4-(4-chlorophenyl)-1-methylpiperidine-3-carboxylate

(3R,4R)-Methyl 4-(4-chlorophenyl)-1-methylpiperidine-3-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(3R,4R)-Methyl 4-(4-chlorophenyl)-1-methylpiperidine-3-carboxylate
IUPAC Namemethyl (3R,4R)-4-(4-chlorophenyl)-1-methylpiperidine-3-carboxylate
Molecular FormulaC14H18ClNO2
Molecular Weight267.76
SMILESCOC(=O)[C@H]1CN(C)CC[C@H]1C1=CC=C(Cl)C=C1
InChI KeyGDFVYUDIAQQDTA-STQMWFEESA-N
Synonym(3S,4S)-Methyl 4-(4-chlorophenyl)-1-methylpiperidine-3-carboxylate;RAC-METHYL-4-(4-CHLOROPHENYL)-1-METHYL PIPERIDINE-3-CARBOXYLATE(1,2);(3S,4S)-Methyl 4-(4-chlorophenyl)-1-Methylpiperidine-3-carboxyla;methyl 4-(4-chlorophenyl)-1-methylpiperidine-4-carboxylate;(3R,4R)-methyl 4-(4-chlorophenyl)-1-methylpiperidine-3-carboxylate;4-(4-chlorophenyl)-1-methyl-3-piperidinecarboxylic acid methyl ester;3-Piperidinecarboxylic acid, 4-(4-chlorophenyl)-1-methyl-, methyl ester, (3R,4R)-rel-
CAS No.205805-13-6

Synthetic Route by SureRoute

1. ACYQSG142 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACYQSG142 route product structure diagram
    ACYQSG142205805-13-6
Inquiry

2. ACYQSG142 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACYQSG142 route product structure diagram
    ACYQSG142205805-13-6
Inquiry

Comments (0)